MESA LABORATORIES INC /CO (MLAB)

Every figure this model derived for MLAB, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 2,800,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 30,695,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 102,848,000 AssetsCurrent 2026-06-30
current liabilities 57,322,000 LiabilitiesCurrent 2026-06-30
equity 188,760,000 StockholdersEquity 2026-06-30
interest expense 10,857,000 InterestExpenseNonoperating 2026-06-30
ocf 55,674,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 249,725,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 16,346,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up MLAB on one particular measure came for.

RatioValue
cash operating margin17.59
current ratio2.4
current ratio reported1.79
deferred revenue growth-3.67
dilution pct2.66
ebit cagr80.13
ebit yoy62.65
fcf margin21.17
growth cv0.98
interest cover2.07
net debt ebitda1.28
operating margin9.0
owner earnings margin14.63
revenue growth3.04
revenue growth per share0.37
roic7.92
rule of 4012.04
sbc pct revenue6.55

What to be careful about

What this model itself distrusts about MLAB's figures. Written by the derivation as it ran, not added afterwards.